Yahoo Canada Web Search

Search results

  1. Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of United States. [5] Today, Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS , cancer , asthma , hypertension , and diabetes for both national and international markets.

  2. Mar 25, 2021 · The Bangladeshi company was founded in 1976. Four years later, Beximco Pharmaceuticals started manufacturing products under the licences of Germany-based Bayer and Upjohn of the US, and launched its own formulation brands three years later. In 1985, it was listed on the Dhaka Stock Exchange. Today, Beximco manufactures and markets its own ...

  3. Beximco Pharmaceuticals Ltd. (Beximco Pharma) is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of USA, Australia, European Union, Canada, and Brazil, among others, and it currently focuses on building presence in many emerging and developed markets ...

  4. Incorporated in 1976, Beximco Pharma started its operation by importing products from global MNCs like Bayer AG, Germany and Upjohn Inc., USA and selling them in the local market. In 1980 the Company began manufacturing these products under licensing arrangement. From that humble beginning, Beximco Pharma has grown from strength to strength,

  5. 5 days ago · Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh. Beximco Pharmaceuticals Limited. Country: Bangladesh: Founded:

  6. Sep 28, 2022 · Beximco’s notable reputation in Bangladesh increased by becoming the exclusive supplier of Serum Institute of India’s COVID-19 vaccine in the country. Between July-December 2021, Beximco distributed eight million doses of this COVID-19 vaccine, facilitated through the Government of Bangladesh. The company also offered full support to ...

  7. People also ask

  8. 2 days ago · In 2023, Beximco Pharmaceuticals's revenue was 39.27 billion, an increase of 13.26% compared to the previous year's 34.67 billion. Earnings were 4.61 billion, a decrease of -9.94%. Financial Statements

  1. People also search for